Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Diabetes Care Devices Market

  • MAR2979136
  • 228 Pages
  • April 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Diabetes Care Devices Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 growing at a CAGR of XX% during the forecast period. The market is divided into two main segments namely glucose mentoring devices and insulin delivery devices.

Diabetes is a chronic condition in which patient has an abnormally high level of sugar (glucose) in the blood. The global diabetes patient pool is expected to reach 385 million in near future because of increasing aging population, unhealthy dietary patterns and sedentary lifestyle.

Market Dynamics

Increase in the diabetes incidence rate caused by rapid urbanization and sedentary lifestyle is the major factor driving the growth of diabetes care devices market. Also, technological advancements of diabetes care devices, consumption of junk food, rise in obese population, the surge in need for diagnosis and treatment of diabetes at a faster rate is further expected to boost the market growth.

Lack of ability to measure the exact level of glucose in blood and adverse effects associated with blood glucose monitoring devices are major factors hindering the market growth. Increase in awareness about diabetes monitoring devices in the developing regions is expected to provide numerous opportunities for the market growth.

Current developments in Insulin delivery devices in the US will allow for strong growth by 2017 and the insulin pen and insulin pump patient share will also increase in near future.

Market Segmentation

The market is segmented into glucose monitoring devices market and insulin delivery devices market. The glucose monitoring devices market is segmented into blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring device. Insulin delivery devices market is further segmented into insulin syringes, insulin pens, insulin pumps and insulin injectors. Based on geography, the market is further divided into North America, Asia-Pacific, Europe and Rest of the world.

Regional/Geographic Analysis

Among the different geographies, the US is the major market, contributing one-third of the global revenue. Asia-Pacific region, especially China, is expected to show a huge growth in this market because of continuous economic growth, the high population suffering from diabetes, drastic change in the lifestyle, and lack of awareness in people for diagnosis and treatment.

Key Players

Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics LifeScan, AgaMatrix, Animas, and DarioHealth.

The report contains comprehensive analysis on:

--> Diabetes Care Devices Market Segments

--> Diabetes Care Devices Market Drivers, Restraints and Opportunities

--> Diabetes Care Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Diabetes Care Devices Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Diabetes Care Devices Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390